Skip to Main Content

Paper Details

Prospective <i>CYP2C19</i> Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial.
Circ Genom Precis Med
31
2020
*17, *2, *3, CYP2C19, CYP2C19 genotype, CYP2C19 loss-of-function alleles, CYP2C19 major alleles, acute coronary syndromes, clopidogrel, loss, loss-of-function allele, men, participants, prasugrel, ticagrelor
Author NameAffiliation
Sony TutejaUniversity of Pennsylvania Perelman School of Medicine
William H MatthaiUniversity of Pennsylvania Perelman School of Medicine
Robert L WilenskyUniversity of Pennsylvania Perelman School of Medicine
Robert L Wilenskyand Evaluative Research Center, Leonard Davis Institute of Health Economics (A.N., University of Pennsylvania Perelman School of Medicine
Daniel M KolanskyUniversity of Pennsylvania Perelman School of Medicine
Daniel J RaderUniversity of Pennsylvania Perelman School of Medicine
Daniel J RaderUniversity of Pennsylvania Perelman School of Medicine
  • 1 - 7

Datasets

Release 1.2